Objective: Supplementation of clinical nutrition with omega-3 fatty acid in fish oil exerts
immune-modulating and organ-protective effects, even after short-term application. The aim of …

… This article will describe the effects of marine n-3 fatty acids … 3 fatty acids in animal models
of RA. The article will then report on a systematic evaluation of marine n-3 fatty acids in clinical …

… Long-chain polyunsaturated fatty acids (LCPUFAs) play … docosahexaenoic acid (DHA), on
various clinical outcomes of preterm … Experimental studies as well as recent clinical trials show …

… outcomes remain inconclusive [5,6,7]. The role of circulating saturated fatty acids (SFA) and
monounsaturated fatty acids (… In contrast, the clinical implications of blood FA status in ESKD …

… oil on plasma phospholipid fatty acids, inflammatory mediators, and clinical outcomes. …
clinical outcomes. It was hypothesised that inclusion of fish oil would increase the n-3 fatty acid …

… beneficially influence infection rate and clinical outcomes in surgical patients probably due
… fatty acids on the prevalence of nosocomial infections and clinical outcomes in medical and …

… , randomized controlled clinical trials focusing … fatty acid postoperatively improves the
inflammatory and immunological function of colorectal cancer patients and their clinical outcomes. …

Background & aims Accumulating scientific evidence supports the benefits of parenteral
nutrition (PN) with fish oil (FO) containing intravenous lipid emulsions (ILEs) on clinical outcomes…

… phospholipid levels of the n-3 fatty acids in fish oil, EPA and … increase in EPA (1 % total fatty
acids) associated with a 12 % … the potential to predict clinical outcomes relevant to standard …

… ABSTRACT: The role of polyunsaturated fatty acids (PUFA) in infant … fatty acids (LC-PUFA),
we have identified 21 studies that have physiological responses or growth as outcomes. …